These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 19101700

  • 1. Inflammatory myopathies with mitochondrial pathology and protein aggregates.
    Temiz P, Weihl CC, Pestronk A.
    J Neurol Sci; 2009 Mar 15; 278(1-2):25-9. PubMed ID: 19101700
    [Abstract] [Full Text] [Related]

  • 2. Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature.
    Papadimas GK, Kokkinis C, Xirou S, Chrysanthou M, Kararizou E, Papadopoulos C.
    Rheumatol Int; 2019 Aug 15; 39(8):1459-1466. PubMed ID: 31055642
    [Abstract] [Full Text] [Related]

  • 3. Morphologic and Molecular Patterns of Polymyositis With Mitochondrial Pathology and Inclusion Body Myositis.
    Kleefeld F, Uruha A, Schänzer A, Nishimura A, Roos A, Schneider U, Goebel HH, Schuelke M, Hahn K, Preusse C, Stenzel W.
    Neurology; 2022 Nov 15; 99(20):e2212-e2222. PubMed ID: 36195449
    [Abstract] [Full Text] [Related]

  • 4. Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.
    Hiniker A, Daniels BH, Lee HS, Margeta M.
    Acta Neuropathol Commun; 2013 Jul 01; 1():29. PubMed ID: 24252466
    [Abstract] [Full Text] [Related]

  • 5. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
    Chahin N, Engel AG.
    Neurology; 2008 Feb 05; 70(6):418-24. PubMed ID: 17881720
    [Abstract] [Full Text] [Related]

  • 6. Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum.
    Zierer LK, Naegel S, Schneider I, Kendzierski T, Kleeberg K, Koelsch AK, Scholle L, Schaefer C, Naegel A, Zierz S, Otto M, Stoltenburg-Didinger G, Kraya T, Stoevesandt D, Mensch A.
    J Neurol; 2024 Jun 05; 271(6):3186-3202. PubMed ID: 38438820
    [Abstract] [Full Text] [Related]

  • 7. Polymyositis with cytochrome C oxidase negative fibers--a pathological and clinical challenge.
    Siepmann T, Tesch M, Krause F, Illigens BM, Stoltenburg-Didinger G.
    Ann Diagn Pathol; 2013 Apr 05; 17(2):183-6. PubMed ID: 23181976
    [Abstract] [Full Text] [Related]

  • 8. T-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.
    Hiniker A, Daniels BH, Margeta M.
    J Neuropathol Exp Neurol; 2016 Mar 05; 75(3):239-45. PubMed ID: 26843609
    [Abstract] [Full Text] [Related]

  • 9. Pleomorphic mitochondrial and different filamentous inclusions in inflammatory myopathies associated with mtDNA deletions.
    Molnar M, Schröder JM.
    Acta Neuropathol; 1998 Jul 05; 96(1):41-51. PubMed ID: 9678512
    [Abstract] [Full Text] [Related]

  • 10. Acquired immune and inflammatory myopathies: pathologic classification.
    Pestronk A.
    Curr Opin Rheumatol; 2011 Nov 05; 23(6):595-604. PubMed ID: 21934500
    [Abstract] [Full Text] [Related]

  • 11. [Pathogenesis of primary inflammatory myopathies].
    Benveniste O, Squier W, Boyer O, Hilton-Jones D, Herson S.
    Presse Med; 2004 Nov 20; 33(20):1444-50. PubMed ID: 15611679
    [Abstract] [Full Text] [Related]

  • 12. Whole-body muscle magnetic resonance imaging in inflammatory myopathy with mitochondrial pathology.
    Cavalcante WCP, da Silva AMS, Mendonça RH, Moreno CAM, Proença BMS, Guimarães JB, Ormond Filho AG, Zanoteli E.
    Front Neurol; 2024 Nov 20; 15():1386293. PubMed ID: 38715692
    [Abstract] [Full Text] [Related]

  • 13. Polymyositis with cytochrome oxidase negative muscle fibres. Early quadriceps weakness and poor response to immunosuppressive therapy.
    Blume G, Pestronk A, Frank B, Johns DR.
    Brain; 1997 Jan 20; 120 ( Pt 1)():39-45. PubMed ID: 9055796
    [Abstract] [Full Text] [Related]

  • 14. Inclusion body myositis presenting as treatment-resistant polymyositis.
    Calabrese LH, Mitsumoto H, Chou SM.
    Arthritis Rheum; 1987 Apr 20; 30(4):397-403. PubMed ID: 3034295
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis and Clinical Development of Sporadic Inclusion Body Myositis and Polymyositis With Mitochondrial Pathology: A Single-Center Retrospective Analysis.
    Winkler M, von Landenberg C, Kappes-Horn K, Neudecker S, Kornblum C, Reimann J.
    J Neuropathol Exp Neurol; 2021 Nov 19; 80(11):1060–1067. PubMed ID: 34643702
    [Abstract] [Full Text] [Related]

  • 16. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
    Eymard B.
    Presse Med; 2003 Oct 25; 32(35):1656-67. PubMed ID: 14631270
    [Abstract] [Full Text] [Related]

  • 17. [Inflammatory myopathies: diagnosis and classifications].
    Dimitri D.
    Presse Med; 2009 Oct 25; 38(7-8):1141-63. PubMed ID: 19282137
    [Abstract] [Full Text] [Related]

  • 18. Inflammatory myopathy with cytochrome oxidase negative muscle fibers: methotrexate treatment.
    Levine TD, Pestronk A.
    Muscle Nerve; 1998 Dec 25; 21(12):1724-8. PubMed ID: 9843075
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathologic features of myositis patients with CD8-MHC-1 complex pathology.
    Ikenaga C, Kubota A, Kadoya M, Taira K, Uchio N, Hida A, Maeda MH, Nagashima Y, Ishiura H, Kaida K, Goto J, Tsuji S, Shimizu J.
    Neurology; 2017 Sep 05; 89(10):1060-1068. PubMed ID: 28794251
    [Abstract] [Full Text] [Related]

  • 20. Inflammatory and toxic myopathies.
    Dalakas MC.
    Curr Opin Neurol Neurosurg; 1992 Oct 05; 5(5):645-54. PubMed ID: 1327303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.